12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Thu, 09 Oct 2025 16:21:52 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Fri, 10 Oct 2025 16:21:52 GMT [17] => vary: Accept-Encoding [18] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=5isgD6pyf9cooy2yIOqvmXRmVzPgYnHqvwH%2F6zdEBbF04JzXRphAutgQ0xBQvtORnyWgZUmAIGu1fUtCtv1g%2B%2Bit8%2FmAfsFwiWUgrB0%3D"}]} [19] => cf-cache-status: DYNAMIC [20] => Speculation-Rules: "/cdn-cgi/speculation" [21] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [22] => Server-Timing: cfEdge;dur=2,cfOrigin;dur=79 [23] => Set-Cookie: UpalLiveSession=eyJpdiI6IklVSllrR1VVM21KV0NxMVwvSEdVZld3PT0iLCJ2YWx1ZSI6ImxVSUpNT25MMyt4WjBBbEFaN04ycmNpNXNXTHN2K3hmM1VtSWtrNGhqMWJmREExMmdIelwvWm8rWlNkXC9CbFwvTjJNYW05eTlGckNHZDJIWG5YRGRKTW53PT0iLCJtYWMiOiJjYjJhMTZjZjZiZWVhYzEyMzA3MzlmNjY5NDMxNmEwNDUyZjY1N2MwZWRmM2JkZGEyMWZjNzM1MGU0YjQ3NzM4In0%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Sun, 08 Oct 2028 16:21:52 GMT [24] => CF-RAY: 98bf36a96d9624ba-KUL [25] => alt-svc: h3=":443"; ma=86400 ) 789

中国疾控中心病毒所所长许文波周日表示，疾控中心已开始针对新型冠状病毒研发疫苗，目前成功分离病毒，正筛选种子毒株(培养病毒的种子)。

他指出，中心也正进行新病毒肺炎的药物筛选。

此外，在病毒试剂方面，由上海一间公司研发的“新型冠状病毒核酸检测试剂盒”，周日正式通过该市医疗器械检测所的检验，成为中国国内首款获批准的新型冠状病毒检测产品。

一旦待获得中国国家药监局的上市批件后，该款试剂盒将下发往各地医院、疾控中心及出入境检验检疫局，用于测定疑似患者是否带有新型冠状病毒。